Author Search Results :: UTM Library Massive Scholar Tracking

1

Clinical significance of P16-positive status and high index of proliferative activity in patients with oropharyngeal squamous cell carcinoma by A. I. Stukan, V. A. Porkhanov, V. N. Bodnya

Published 2020-04-01

Get full text

Article

2

Significance and possible causes of hormone receptor expression loss in metastatic breast cancer. Phenotypic evolution of luminal BRCA1-associated breast cancer to triple ne... by A. I. Stukan, Z. K. Khachmamuk, V. V. Antipova, A. V. Dzagashtokova

Published 2022-12-01

Get full text

Article

3

Pathogenetic rationale for the use of cell therapy in lung injury associated with SARS-CoV-2 by A. I. Stukan, I. V. Gilevich, V. A. Porhanov, V. N. Bodnya

Published 2020-06-01

Get full text

Article

4

Mechanisms of metastasis and development of resistance to therapy in breast cancer. A clinical case of the effectiveness of ixabepilone in hormone-receptorpositive breast cancer wi... by A. I. Stukan, A. Y. Goryainova, S. V. Sharov, D. V. Andreev, E. V. Lymar

Published 2021-08-01

Get full text

Article

5

Molecular features evaluation of metastatic foci as the basis for metastatic breast cancer treatment personalization. Is there a place of CDK4/6-inhibitors in late-line therapy aft... by A. I. Stukan, A. Y. Goryainova, E. V. Lymar, S. V. Sharov, V. V. Antipova

Published 2021-12-01

Get full text

Article

6

PREDICTORS OF AGGRESSIVE DIFFERENTIATED THYROID CANCER. A REPORT OF A CASE OF PAPILLARY THYROID CANCER by R. A. Murashko, A. S. Shatokhina, A. I. Stukan, D. V. Andreev, E. V. Dulina

Published 2017-11-01

Get full text

Article

7

Evolution of the CDK4/6 inhibitor abemaciclib: from palliative to adjuvant therapy. Clinical experience with abemaciclib in patients with hormone-receptor-positive, HER2-negative b... by A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, E. V. Lymar

Published 2022-06-01

Get full text

Article

8

Induction of ovarian steroidogenesis as an additional potential risk factor for progression in premenopausal patients with hormone-receptor-positive breast cancer receiving tamoxif... by A. Yu. Goryainova, A. I. Stukan, E. V. Lymar, Z. K. Khachmamuk, I. G. Selezneva

Published 2022-06-01

Get full text

Article

9

THE ROLE OF HUMAN PAPILLOMAVIRUS IN DEVELOPMENT OF OROPHARYNGEAL CANCER by A. I. Stukan, V. N. Bodnya, E. V. Dulina, A. A. Leonov, V. I. Aleksandrov

Published 2016-10-01

Get full text

Article

10

TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA ACCORDING ON THE SPECIFIC MOLECULAR FEATURES OF THE TUMOR (A LITERATURE REVIEW) by A. I. Stukan, R. A. Murashko, V. N. Bodnya, O. Yu. Chukhray, E. V. Dulina

Published 2017-11-01

Get full text

Article

11

Liquid biopsy: the current state of the issue by E. A. Pasechnikova, V. N. Bodnya, S. V. Sharov, D. V. Kadomtsev, A. Y. Georgieva, A. I. Stukan

Published 2021-09-01

Get full text

Article

12

Role of pre-metastatic niche in organ specificity of breast cancer metastasis. Influence on metastatic potential as a basis for CDK4/6-inhibition efficacy in early therapy of disse... by A. I. Stukan, A. Yu. Goryainova, E. V. Lymar, S. V. Sharov, D. V. Andreev, V. V. Antipova

Published 2021-12-01

Get full text

Article

13

Molecular and genetic profile of head and neck squamous cell carcinoma by A. I. Stukan, V. A. Porhanov, V. N. Bodnya, O. Yu. Chuhraj, Y. M. Makarova, I. S. Elizbaryan

Published 2018-10-01

Get full text

Article

14

Efficacy of the immune checkpoint inhibitor nivolumab in the treatment of advanced hepatocellular carcinoma with the exhausted possibilities of therapy with tyrosine kinase inhibit... by A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, O. I. Kirsanova, E. V. Lymar

Published 2021-12-01

Get full text

Article

15

Causes of resistance to PARP inhibitors and ways to overcome it. Case report of aggressive BRCA-related breast cancer by A. I. Stukan, A. Yu. Goryainova, S. V. Sharov, O. A. Goncharova, Z. K. Khachmamuk, V. V. Durov

Published 2022-05-01

Get full text

Article

16

Adaptive immune response in pathogenesis and treatment of head and neck squamous cell carcinoma: the influence of immunosuppression factors and gender by A. I. Stukan, R. A. Murashko, N. A. Tsygan, A. Yu. Goryainova, O. N. Nefedov, V. A. Porkhanov

Published 2022-12-01

Get full text

Article

17

Human papillomavirus-associated oropharyngeal carcinoma: trends in epidemiology and methods for detecting the virus in tumors by A. I. Stukan', O. Yu. Chukhray, V. A. Porkhanov, R. A. Murashko, V. N. Bodnya, Yu. M. Makarova

Published 2018-11-01

Get full text

Article

18

Khimioluchevaya terapiya ploskokletochnogo mestnorasprostranennogo anal'nogo raka (klinicheskiy sluchay) by K S Elizbaryan, M V Kazantseva, I S Davidenko, S N Potemin, D V Andreev, O P Burdik, A I Stukan'

Published 2012-09-01

Get full text

Article

19

Tumor immune microenvironment and apoptotic markers in breast cancer patients carrying BRCA1 gene mutations by A. I. Stukan, A. Yu. Goryainova, O. Yu. Chukhray, S. D. Maksimenko, E. N. Imyanitov, S. V. Sharov, Z. K. Khachmamuk

Published 2022-09-01

Get full text

Article

20

Dynamic changes in the tumor microenvironment under the effect of estradiol as a diagnostic tool and target for targeted cancer therapy by A. I. Stukan, A. Yu. Goryainova, A. A. Meshcheryakov, V. A. Porkhanov, R. A. Murashko, S. V. Sharov, V. N. Bodnya

Published 2022-04-01

Get full text

Article

Clinical significance of P16-positive status and high index of proliferative activity in patients with oropharyngeal squamous cell carcinoma by A. I. Stukan, V. A. Porkhanov, V. N. Bodnya

Significance and possible causes of hormone receptor expression loss in metastatic breast cancer. Phenotypic evolution of luminal <i>BRCA1</i>-associated breast cancer to triple ne... by A. I. Stukan, Z. K. Khachmamuk, V. V. Antipova, A. V. Dzagashtokova

Pathogenetic rationale for the use of cell therapy in lung injury associated with SARS-CoV-2 by A. I. Stukan, I. V. Gilevich, V. A. Porhanov, V. N. Bodnya

Mechanisms of metastasis and development of resistance to therapy in breast cancer. A clinical case of the effectiveness of ixabepilone in hormone-receptorpositive breast cancer wi... by A. I. Stukan, A. Y. Goryainova, S. V. Sharov, D. V. Andreev, E. V. Lymar

Molecular features evaluation of metastatic foci as the basis for metastatic breast cancer treatment personalization. Is there a place of CDK4/6-inhibitors in late-line therapy aft... by A. I. Stukan, A. Y. Goryainova, E. V. Lymar, S. V. Sharov, V. V. Antipova

PREDICTORS OF AGGRESSIVE DIFFERENTIATED THYROID CANCER. A REPORT OF A CASE OF PAPILLARY THYROID CANCER by R. A. Murashko, A. S. Shatokhina, A. I. Stukan, D. V. Andreev, E. V. Dulina

Evolution of the CDK4/6 inhibitor abemaciclib: from palliative to adjuvant therapy. Clinical experience with abemaciclib in patients with hormone-receptor-positive, HER2-negative b... by A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, E. V. Lymar

Induction of ovarian steroidogenesis as an additional potential risk factor for progression in premenopausal patients with hormone-receptor-positive breast cancer receiving tamoxif... by A. Yu. Goryainova, A. I. Stukan, E. V. Lymar, Z. K. Khachmamuk, I. G. Selezneva

THE ROLE OF HUMAN PAPILLOMAVIRUS IN DEVELOPMENT OF OROPHARYNGEAL CANCER by A. I. Stukan, V. N. Bodnya, E. V. Dulina, A. A. Leonov, V. I. Aleksandrov

TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA ACCORDING ON THE SPECIFIC MOLECULAR FEATURES OF THE TUMOR (A LITERATURE REVIEW) by A. I. Stukan, R. A. Murashko, V. N. Bodnya, O. Yu. Chukhray, E. V. Dulina

Liquid biopsy: the current state of the issue by E. A. Pasechnikova, V. N. Bodnya, S. V. Sharov, D. V. Kadomtsev, A. Y. Georgieva, A. I. Stukan

Role of pre-metastatic niche in organ specificity of breast cancer metastasis. Influence on metastatic potential as a basis for CDK4/6-inhibition efficacy in early therapy of disse... by A. I. Stukan, A. Yu. Goryainova, E. V. Lymar, S. V. Sharov, D. V. Andreev, V. V. Antipova

Molecular and genetic profile of head and neck squamous cell carcinoma by A. I. Stukan, V. A. Porhanov, V. N. Bodnya, O. Yu. Chuhraj, Y. M. Makarova, I. S. Elizbaryan

Efficacy of the immune checkpoint inhibitor nivolumab in the treatment of advanced hepatocellular carcinoma with the exhausted possibilities of therapy with tyrosine kinase inhibit... by A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, O. I. Kirsanova, E. V. Lymar

Causes of resistance to PARP inhibitors and ways to overcome it. Case report of aggressive <i>BRCA</i>-related breast cancer by A. I. Stukan, A. Yu. Goryainova, S. V. Sharov, O. A. Goncharova, Z. K. Khachmamuk, V. V. Durov

Adaptive immune response in pathogenesis and treatment of head and neck squamous cell carcinoma: the influence of immunosuppression factors and gender by A. I. Stukan, R. A. Murashko, N. A. Tsygan, A. Yu. Goryainova, O. N. Nefedov, V. A. Porkhanov

Human papillomavirus-associated oropharyngeal carcinoma: trends in epidemiology and methods for detecting the virus in tumors by A. I. Stukan', O. Yu. Chukhray, V. A. Porkhanov, R. A. Murashko, V. N. Bodnya, Yu. M. Makarova

Khimioluchevaya terapiya ploskokletochnogo mestnorasprostranennogo anal'nogo raka (klinicheskiy sluchay) by K S Elizbaryan, M V Kazantseva, I S Davidenko, S N Potemin, D V Andreev, O P Burdik, A I Stukan'

Tumor immune microenvironment and apoptotic markers in breast cancer patients carrying <I>BRCA1</I> gene mutations by A. I. Stukan, A. Yu. Goryainova, O. Yu. Chukhray, S. D. Maksimenko, E. N. Imyanitov, S. V. Sharov, Z. K. Khachmamuk

Dynamic changes in the tumor microenvironment under the effect of estradiol as a diagnostic tool and target for targeted cancer therapy by A. I. Stukan, A. Yu. Goryainova, A. A. Meshcheryakov, V. A. Porkhanov, R. A. Murashko, S. V. Sharov, V. N. Bodnya

Clinical significance of P16-positive status and high index of proliferative activity in patients with oropharyngeal squamous cell carcinoma by A. I. Stukan, V. A. Porkhanov, V. N. Bodnya

Significance and possible causes of hormone receptor expression loss in metastatic breast cancer. Phenotypic evolution of luminal <i>BRCA1</i>-associated breast cancer to triple ne... by A. I. Stukan, Z. K. Khachmamuk, V. V. Antipova, A. V. Dzagashtokova

Pathogenetic rationale for the use of cell therapy in lung injury associated with SARS-CoV-2 by A. I. Stukan, I. V. Gilevich, V. A. Porhanov, V. N. Bodnya

Mechanisms of metastasis and development of resistance to therapy in breast cancer. A clinical case of the effectiveness of ixabepilone in hormone-receptorpositive breast cancer wi... by A. I. Stukan, A. Y. Goryainova, S. V. Sharov, D. V. Andreev, E. V. Lymar

Molecular features evaluation of metastatic foci as the basis for metastatic breast cancer treatment personalization. Is there a place of CDK4/6-inhibitors in late-line therapy aft... by A. I. Stukan, A. Y. Goryainova, E. V. Lymar, S. V. Sharov, V. V. Antipova

PREDICTORS OF AGGRESSIVE DIFFERENTIATED THYROID CANCER. A REPORT OF A CASE OF PAPILLARY THYROID CANCER by R. A. Murashko, A. S. Shatokhina, A. I. Stukan, D. V. Andreev, E. V. Dulina

Evolution of the CDK4/6 inhibitor abemaciclib: from palliative to adjuvant therapy. Clinical experience with abemaciclib in patients with hormone-receptor-positive, HER2-negative b... by A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, E. V. Lymar

Induction of ovarian steroidogenesis as an additional potential risk factor for progression in premenopausal patients with hormone-receptor-positive breast cancer receiving tamoxif... by A. Yu. Goryainova, A. I. Stukan, E. V. Lymar, Z. K. Khachmamuk, I. G. Selezneva

THE ROLE OF HUMAN PAPILLOMAVIRUS IN DEVELOPMENT OF OROPHARYNGEAL CANCER by A. I. Stukan, V. N. Bodnya, E. V. Dulina, A. A. Leonov, V. I. Aleksandrov

TREATMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA ACCORDING ON THE SPECIFIC MOLECULAR FEATURES OF THE TUMOR (A LITERATURE REVIEW) by A. I. Stukan, R. A. Murashko, V. N. Bodnya, O. Yu. Chukhray, E. V. Dulina

Liquid biopsy: the current state of the issue by E. A. Pasechnikova, V. N. Bodnya, S. V. Sharov, D. V. Kadomtsev, A. Y. Georgieva, A. I. Stukan

Role of pre-metastatic niche in organ specificity of breast cancer metastasis. Influence on metastatic potential as a basis for CDK4/6-inhibition efficacy in early therapy of disse... by A. I. Stukan, A. Yu. Goryainova, E. V. Lymar, S. V. Sharov, D. V. Andreev, V. V. Antipova

Molecular and genetic profile of head and neck squamous cell carcinoma by A. I. Stukan, V. A. Porhanov, V. N. Bodnya, O. Yu. Chuhraj, Y. M. Makarova, I. S. Elizbaryan

Efficacy of the immune checkpoint inhibitor nivolumab in the treatment of advanced hepatocellular carcinoma with the exhausted possibilities of therapy with tyrosine kinase inhibit... by A. Yu. Goryainova, A. I. Stukan, R. A. Murashko, S. V. Sharov, O. I. Kirsanova, E. V. Lymar

Causes of resistance to PARP inhibitors and ways to overcome it. Case report of aggressive <i>BRCA</i>-related breast cancer by A. I. Stukan, A. Yu. Goryainova, S. V. Sharov, O. A. Goncharova, Z. K. Khachmamuk, V. V. Durov

Adaptive immune response in pathogenesis and treatment of head and neck squamous cell carcinoma: the influence of immunosuppression factors and gender by A. I. Stukan, R. A. Murashko, N. A. Tsygan, A. Yu. Goryainova, O. N. Nefedov, V. A. Porkhanov

Human papillomavirus-associated oropharyngeal carcinoma: trends in epidemiology and methods for detecting the virus in tumors by A. I. Stukan', O. Yu. Chukhray, V. A. Porkhanov, R. A. Murashko, V. N. Bodnya, Yu. M. Makarova

Khimioluchevaya terapiya ploskokletochnogo mestnorasprostranennogo anal'nogo raka (klinicheskiy sluchay) by K S Elizbaryan, M V Kazantseva, I S Davidenko, S N Potemin, D V Andreev, O P Burdik, A I Stukan'

Tumor immune microenvironment and apoptotic markers in breast cancer patients carrying <I>BRCA1</I> gene mutations by A. I. Stukan, A. Yu. Goryainova, O. Yu. Chukhray, S. D. Maksimenko, E. N. Imyanitov, S. V. Sharov, Z. K. Khachmamuk

Dynamic changes in the tumor microenvironment under the effect of estradiol as a diagnostic tool and target for targeted cancer therapy by A. I. Stukan, A. Yu. Goryainova, A. A. Meshcheryakov, V. A. Porkhanov, R. A. Murashko, S. V. Sharov, V. N. Bodnya

Search Tools: